HOSPITAL MATER DEI S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.96 BRL | +8.23% |
|
+1.36% | -28.62% |
| 04-05 | Hospital Mater Dei S.A. announces an Equity Buyback for 9,613,168 shares, representing 2.51% of its issued share capital. | CI |
| 04-04 | Hospital Mater Dei S.A. authorizes a Buyback Plan. | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,161 | 2,757 | 3,190 | 2,220 | - | - |
| Enterprise Value (EV) 1 | 5,574 | 4,359 | 3,190 | 3,692 | 3,592 | 3,120 |
| P/E ratio | 30.7 x | 28.8 x | 27.8 x | 12.1 x | 7.2 x | - |
| Yield | 0.67% | - | - | 2.01% | 3.05% | - |
| Capitalization / Revenue | 5.04 x | 1.56 x | 1.46 x | 0.9 x | 0.79 x | 0.73 x |
| EV / Revenue | 5.44 x | 2.47 x | 1.46 x | 1.5 x | 1.28 x | 1.02 x |
| EV / EBITDA | 18.1 x | 10.2 x | 6.07 x | 6.03 x | 5 x | 3.91 x |
| EV / FCF | -30.5 x | -16.7 x | - | 31.4 x | 16.9 x | 12.3 x |
| FCF Yield | -3.28% | -6% | - | 3.18% | 5.92% | 8.16% |
| Price to Book | - | 1.75 x | - | 1.13 x | 0.97 x | - |
| Nbr of stocks (in thousands) | 382,330 | 382,330 | 382,043 | 382,043 | - | - |
| Reference price 2 | 13.50 | 7.210 | 8.350 | 5.810 | 5.810 | 5.810 |
| Announcement Date | 29/03/22 | 15/03/23 | 28/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 717.9 | 1,024 | 1,763 | 2,188 | 2,463 | 2,804 | 3,057 |
| EBITDA 1 | - | 308.4 | 428 | 525.6 | 612.7 | 717.8 | 798 |
| EBIT 1 | - | 242.3 | 337.9 | 423.6 | 515.6 | 619.3 | 715 |
| Operating Margin | - | 23.65% | 19.16% | 19.36% | 20.94% | 22.09% | 23.39% |
| Earnings before Tax (EBT) 1 | - | - | 185.8 | 208.8 | 271.4 | 398 | 402 |
| Net income 1 | - | 146.8 | 103.5 | 119.7 | 165.8 | 270 | 234 |
| Net margin | - | 14.34% | 5.87% | 5.47% | 6.73% | 9.63% | 7.65% |
| EPS 2 | 0.2200 | 0.4400 | 0.2500 | 0.3000 | 0.4800 | 0.8069 | - |
| Free Cash Flow 1 | - | -182.6 | -261.7 | - | 117.5 | 212.5 | 254.5 |
| FCF margin | - | -17.83% | -14.84% | - | 4.77% | 7.58% | 8.32% |
| FCF Conversion (EBITDA) | - | - | - | - | 19.18% | 29.6% | 31.89% |
| FCF Conversion (Net income) | - | - | - | - | 70.86% | 78.71% | 108.76% |
| Dividend per Share 2 | - | 0.0900 | - | - | 0.1167 | 0.1774 | - |
| Announcement Date | 11/02/21 | 29/03/22 | 15/03/23 | 28/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 240.4 | 288.2 | 342.7 | 466.2 | 473.9 | 512.1 | 524.1 | 554.2 | 568.2 | 541.2 | 564.2 |
| EBITDA 1 | 71.95 | 78.6 | 89.93 | 120.4 | 119.8 | 121.8 | 131.9 | 147 | 134.3 | 112.5 | 132.8 |
| EBIT | - | 45.31 | 64.89 | 87.08 | 94.13 | 91.81 | 106.2 | 122.1 | 108.8 | 86.5 | - |
| Operating Margin | - | 15.72% | 18.93% | 18.68% | 19.86% | 17.93% | 20.27% | 22.04% | 19.14% | 15.98% | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - |
| Net income 1 | - | - | 26.58 | 29.22 | 33.72 | 13.97 | 27.21 | 38.09 | 28.55 | 25.8 | 34 |
| Net margin | - | - | 7.76% | 6.27% | 7.12% | 2.73% | 5.19% | 6.87% | 5.02% | 4.77% | 6.03% |
| EPS | 0.1800 | -0.0600 | 0.0600 | 0.0800 | 0.0700 | 0.0300 | 0.0700 | 0.0900 | 0.0700 | 0.0700 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 09/11/21 | 29/03/22 | 12/05/22 | 10/08/22 | 09/11/22 | 15/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 28/03/24 | - |
1BRL in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 412 | 1,602 | - | 1,472 | 1,372 | 901 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 1.336 x | 3.744 x | - | 2.359 x | 1.912 x | 1.128 x |
| Free Cash Flow 1 | - | -183 | -262 | - | 118 | 213 | 255 |
| ROE (net income / shareholders' equity) | - | 17.2% | 6.36% | - | 10% | 12.8% | 13.3% |
| ROA (Net income/ Total Assets) | - | 6.2% | 2.29% | - | 4.15% | 5.43% | - |
| Assets 1 | - | 2,368 | 4,512 | - | 4,486 | 4,975 | - |
| Book Value Per Share 2 | - | - | 4.110 | - | 5.120 | 5.960 | - |
| Cash Flow per Share 2 | - | - | -0.1500 | - | 0.5400 | - | - |
| Capex 1 | - | 114 | 200 | - | 218 | 169 | 191 |
| Capex / Sales | - | 11.12% | 11.34% | - | 8.85% | 6.03% | 6.26% |
| Announcement Date | 11/02/21 | 29/03/22 | 15/03/23 | 28/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
5.81
BRL
Average target price
9.85
BRL
Spread / Average Target
+69.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.62% | 438M | |
| -15.68% | 16.57B | |
| +4.50% | 12.51B | |
| +4.48% | 11.69B | |
| +6.18% | 10.36B | |
| +26.24% | 8.38B | |
| -2.87% | 7.75B | |
| +20.39% | 7.12B | |
| +3.24% | 6.6B | |
| +46.01% | 4.54B |
- Stock Market
- Equities
- MATD3 Stock
- Financials Hospital Mater Dei S.A.
